Team: Adera

School Affiliation: Washington University

Description: Adera is an AI-powered sleep enhancement headband and app that uses real-time neuroadaptive feedback.

Problem:

Adera addresses the global sleep crisis, which affects over 1 billion individuals worldwide and costs the global economy approximately $680 billion annually due to reduced productivity and increased healthcare expenses. Poor sleep impairs cognitive performance, increases the risk of chronic diseases, and contributes to mental health issues. The COVID-19 pandemic has exacerbated sleep disorders, with a 60% rise in insomnia cases. Existing solutions such as sleep trackers passively monitor sleep without intervention, and sleep medications often lead to dependency and health risks. This growing crisis demands an immediate and effective solution that not only tracks but also actively improves sleep quality.

Solution:

Adera’s AI-powered sleep enhancement headband and app provide real-time sleep optimization using neuroadaptive feedback, biometric analysis, and environmental modulation. Unlike traditional trackers, Adera dynamically adjusts soundscapes, lighting, and temperature based on users’ physiological signals to optimize deep sleep and REM cycles. Its biometric sensors monitor brainwaves (EEG), heart rate variability (HRV), respiration rate, temperature, and movement, allowing its AI engine to predict and prevent sleep disturbances. This adaptive technology offers a non-invasive, drug-free, and personalized solution that continuously improves sleep quality over time, promoting cognitive performance, reducing stress, and enhancing overall well-being.

Market:

Adera targets the $585 billion global sleep economy, projected to surpass $1 trillion by 2030. Its serviceable available market (SAM) within AI-powered sleep solutions is valued at $30 billion, with a goal to capture $1.5 billion within five years. The primary B2C segments include individuals with sleep disorders, high-performance professionals, and wellness enthusiasts seeking drug-free sleep optimization. On the B2B front, Adera targets corporate wellness programs, healthcare providers, and smart home ecosystems, offering scalable solutions that enhance employee productivity, reduce healthcare costs, and integrate seamlessly with smart devices like Alexa and Google Nest.

Competition:

Adera differentiates itself from passive trackers like Oura, WHOOP, and Fitbit by providing real-time, AI-driven sleep enhancement rather than mere data collection. Unlike smart beds such as Eight Sleep, Adera’s headband integrates EEG, HRV, and respiration data to dynamically adjust environmental factors. Compared to brain stimulation devices like Dreem and Philips SmartSleep, Adera is non-invasive, avoiding electrical stimulation risks while offering real-time, adaptive optimization. Its proprietary AI engine continuously learns from biometric feedback to personalize sleep routines, ensuring superior results in both deep sleep and REM enhancement. This multi-sensor, real-time feedback approach positions Adera as a market leader in sleep technology.

Value Creation:

Adera’s scalable business model includes direct-to-consumer hardware sales ($299.99 per unit), monthly subscriptions for advanced AI features ($19.99/month), and B2B partnerships with corporate wellness programs and healthcare providers. With a projected revenue of $402.7 million by Year 6 and a net profit margin of 62%, Adera offers both financial sustainability and measurable social impact. By improving sleep quality, Adera enhances cognitive performance, reduces stress, and lowers healthcare costs associated with sleep-related conditions. Its non-invasive, drug-free approach aligns with the growing consumer preference for natural wellness solutions, ensuring long-term market relevance and profitability.

The Team:

Jasmine Kim (Bachelors in Philosophy-Neuroscience-Psychology, Entrepreneurship, May 2025)

© Copyright 2025 Poets & Quants. All rights reserved. This article may not be republished, rewritten or otherwise distributed without written permission. To reprint or license this article or any content from Poets & Quants, please submit your request HERE.